المؤلفون: Danai Dima, Nerea Lopetegui‐Lia, Olisaemeka Ogbue, Bennett Osantowski, Fauzia Ullah, Xuefei Jia, Jung Min Song, Brian Gastman, James Isaacs, Lucy Boyce Kennedy, Pauline Funchain

المصدر: Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)

مصطلحات موضوعية: adjuvant therapy, adverse events, immunotherapy, stage III melanoma, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/00d7e2c1a4e64eb7bb23bb9111e3990d

المؤلفون: Marcin Ziętek, Marcin Zdzienicki, Jędrzej Wierzbicki, Bożena Cybulska-Stopa, Maria Krotewicz, Wojciech Łobaziewicz, Wojciech M. Wysocki, Grażyna Kamińska-Winciorek, Maria Turska-d’Amico, Piotr Rutkowski

المصدر: Advances in Dermatology and Allergology, Vol 39, Iss 6, Pp 1141-1150 (2022)

مصطلحات موضوعية: stage iii melanoma, systemic therapy, adjuvant therapy, immunotherapy, targeted therapy, Dermatology, RL1-803, Internal medicine, RC31-1245

وصف الملف: electronic resource

Relation: https://www.termedia.pl/Survival-of-patients-with-stage-IIIC-and-IIID-melanomas-r-nwith-nodal-metastases-in-the-light-of-new-therapies,7,47934,1,1.html; https://doaj.org/toc/1642-395X; https://doaj.org/toc/2299-0046

URL الوصول: https://doaj.org/article/59788f19e8e24f22812295b7a890bd05

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bloemendal M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Rietveld MJA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van Willigen WW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., Westdorp H; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Boudewijns S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Koornstra RHT; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Adang EMM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Ottevanger PB; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., de Vries IJM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. jolanda.devries@radboudumc.nl.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands. jolanda.devries@radboudumc.nl., Bol KF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2019 Jun; Vol. 21 (6), pp. 774-780. Date of Electronic Publication: 2018 Nov 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy* , Quality of Life*, Adjuvants, Immunologic/*therapeutic use , Dendritic Cells/*transplantation , Melanoma/*therapy, Adult ; Aged ; Dendritic Cells/immunology ; Female ; Follow-Up Studies ; Humans ; Male ; Melanoma/immunology ; Middle Aged ; Neoplasm Staging ; Prospective Studies ; Surveys and Questionnaires ; Young Adult

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.